Fri.Jul 05, 2024

article thumbnail

STAT+: GLP-1s lower risk of 10 obesity-associated cancers, study shows

STAT

New research finds that the GLP-1 class of drugs — glucagon-like peptide receptor agonists — is more effective in mitigating the risk of 10 obesity-associated cancers than its type 2 diabetes drug alternatives. The retrospective study, published Friday in JAMA Network Open , measured results for a cohort of more than 1.6 million patients with type 2 diabetes from 2005 to 2018 who were prescribed GLP-1s, insulin, or metformin.

Diabetes 361
article thumbnail

Community pharmacy contract will be ‘one of new government’s first tasks’

The Pharmacist

Negotiating the new community pharmacy contract will be one of the first tasks of the new Labour government, Community Pharmacy England (CPE) has said. But even in a 'best-case scenario', negotiations might not begin for several weeks, CPE suggested. Commenting on the Labour Party’s win this morning, CPE chief executive Janet Morrison said that concluding […] The post Community pharmacy contract will be ‘one of new government’s first tasks’ appeared first on The Pharmacist.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: AbbVie dramatically outspent its pharma company rivals in 2023 to promote its drugs to doctors

STAT

WASHINGTON — Pharmaceutical giant AbbVie paid health care providers roughly $145.7 million last year to promote its drugs, according to a STAT analysis of newly released government data. The massive sum spent by AbbVie, the maker of the mega blockbuster anti-inflammatory drug Humira, is the most a pharmaceutical company has spent on marketing to doctors since such data became available in 2017.

article thumbnail

Innovation in generics: Increased efficiency through peptide API synthesis expertise

pharmaphorum

Discover how innovative approaches and specialised expertise in peptide API synthesis are increasing efficiency and driving advancements in the manufacturing of Active Pharmaceutical Ingredients (API).

115
115
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Constructing an atlas of human biology in space: Q&A with Christopher Mason

STAT

After several delays, the highly anticipated first commercial spacewalk is set to launch later this summer as part of SpaceX’s Polaris Dawn mission , propelling four civilian astronauts more than 430 miles above Earth. Among those eagerly awaiting the mission’s findings is Christopher Mason , a geneticist and computational biologist who studies the effects of space on the human body.

Packaging 304
article thumbnail

NeuroSense Therapeutics shares positive results of lead candidate in ALS

Pharma Times

The neurodegenerative disease currently affects more than 200,000 people worldwide

151
151

More Trending

article thumbnail

Wes Streeting confirmed as new health secretary

The Pharmacist

Wes Streeting has been appointed as the new Labour government's health secretary, a position he shadowed in opposition. Community Pharmacy England (CPE) chief executive Janet Morrison welcomed him to his role, saying that CPE had been 'encouraged by his recognition of the critical pharmacy funding pressures and support for the sector on the campaign trail'. […] The post Wes Streeting confirmed as new health secretary appeared first on The Pharmacist.

article thumbnail

Opinion: My stalled relay race to get access to ALS drugs in development

STAT

One night in November 2018, I fell while crossing a street in Subic Bay, a U.S. naval logistics station in The Philippines. My face whacked the asphalt. Lying in the path of oncoming traffic, I couldn’t move a muscle. After 45 seconds of terror, I was able to stand up and haul myself to the other side. Six months later, after dealing with symptoms like my left leg buckling unexpectedly and being extra tired hauling my tools around on the job, a doctor told me I had amyotrophic lateral scl

360
360
article thumbnail

The pharmaceutical retail industry: a paradigm shift for growth and compliance driven by data visibility

Express Pharma

The pharmaceutical retail industry presents a paradox: it is highly regulated yet fragmented. This dichotomy arises from the diverse range of stakeholders, each with their own interests and priorities. This fragmentation poses challenges for medical and more retailers in complying with regulations, tracking inventory, and preventing counterfeit products from infiltrating the supply chain.

article thumbnail

STAT+: U.K. trade group scolds Novo, Novartis, Pfizer, and Otsuka for violating industry codes

STAT

Four large drugmakers — Novartis, Pfizer, Novo Nordisk, and Otsuka Pharmaceutical — were scolded by a U.K. industry trade group for violating a voluntary code that is designed to bolster marketing practices. In each case, the companies were chastised for discrediting — and reducing confidence in — the industry, while Novo Nordisk was singled out for a public reprimand.

277
277
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Pharma responds to 2024 UK General Election

European Pharmaceutical Review

Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government. Association of the British Pharmaceutical Industry (ABPI) The new government now needs to hit the ground running and rapidly set out a clear, detailed plan” “During its campaign, Labour was right to single out the UK’s life sciences sector as a critical partner fo

article thumbnail

Study reveals mobile phone data can help map the spread of pathogens

Pharma Times

Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide

article thumbnail

Labour, the NHS, and life sciences: Partnerships and people

pharmaphorum

Explore the vital partnerships and people involved in shaping Labour's policies on the NHS, healthcare, and life sciences during the general election. Learn more about the key areas of focus and priorities.

113
113
article thumbnail

Innovent sells its share in CAR T-cell therapy to IASO Bio for 18% equity

Pharmaceutical Technology

Fucaso, a BCMA CAR T-cell therapy, is co-developed by Innovent and IASO Bio and was approved to treat multiple myeloma in China last month.

97
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

The Omentum Project - a frank and honest discussion with two time ovarian cancer survivor, Meg Wilkinson

Outsourcing Pharma

Meg Wilkinson, a resilient cancer survivor, recently sat down with OSP editor Liza Laws to discuss her journey from diagnosis to founding the Omentum Project.

90
article thumbnail

Private equity firms ‘eyeing $20bn for Sanofi consumer unit’

pharmaphorum

Reports indicate that private equity firms Bain Capital and Cinven may be contemplating a bid for the consumer health division of Sanofi.

110
110
article thumbnail

AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC

Pharmaceutical Technology

Approval is based on positive data from the Phase III FLAURA2 trial where Tagrisso plus chemotherapy showed PFS of 24.4 months.

article thumbnail

Single-cell multi-omics and oncological potential

pharmaphorum

Learn about Professor Melanie Bailey's research on single-cell multi-omics and its oncological potential through the company SEISMIC. Discover the groundbreaking work and contributions to the field.

104
104
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Popular prescription weight loss drugs linked to uncommon blinding condition

World Pharma News

A new study led by investigators from Mass Eye and Ear found that patients prescribed semaglutide (as Ozempic or Wegovy) for diabetes or weight loss had a higher risk of having a potentially blinding eye condition called NAION than similar patients who had not been prescribed these drugs. Notably, the study found people with diabetes who had been prescribed semaglutide by their physician and then filled the prescription were more than four times more likely to be diagnosed with NAION.

article thumbnail

NHS will take more than one term to fix, says Streeting

pharmaphorum

After Labour landslide in UK general election, former shadow health secretary West Streeting sets out his objectives for the NHS.

105
105
article thumbnail

Improving the Efficacy of Genetic Medicines

PharmaTech

Shawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization

69
article thumbnail

Community pharmacist Sadik Al-Hassan elected as MP

The Pharmacist

Community pharmacist Sadik Al-Hassan has been elected as the MP for Somerset North. The Labour representative beat Conservative candidate Liam Fox, who has held the seat for the last 32 years. Mr Al-Hassan, whose handle on X is @Sadik4Pharmacy, has previously used his platform to speak about the challenges facing the community pharmacy sector. During […] The post Community pharmacist Sadik Al-Hassan elected as MP appeared first on The Pharmacist.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Denmark?

Drug Patent Watch

This chart shows the drugs with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

59
article thumbnail

Alembic receives tentative approval from USFDA for Ivosidenib Tablets

Pharmaceutical Business Review

This approval marks a significant milestone for the company, indicating that its product is therapeutically equivalent to the reference listed Tibsovo Tablets, 250mg of Servier Pharmaceuticals. Ivosidenib is a targeted therapy designed for patients with a specific IDH1 mutation, which can be detected using an FDA-approved test. The medication is indicated for use in various patient groups, including those with newly diagnosed Acute Myeloid Leukemia (AML) who are over 75 years old or have other h

Dosage 59
article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

59
article thumbnail

Community pharmacy ‘crucial’ to Labour’s vision for primary care

The Pharmacist

Community pharmacy leaders have highlighted the crucial role of the sector in the Labour government's primary care plans, but said that expanded services can only be delivered with sustainable funding for the network. This comes as the Labour Party is set to form the next Government following a landslide victory in yesterday’s general election. Meanwhile, […] The post Community pharmacy ‘crucial’ to Labour’s vision for primary care appeared first on The Pharmacist.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

New patent expiration for Abbvie drug ORILISSA

Drug Patent Watch

Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.

59
article thumbnail

Top 7 AI Mistakes Pharma Companies Make

Viseven

AI can do all sorts of marvelous things these days. It can create beautiful images, craft excellent articles, and even write great songs. Even though the technology is capable of many things, it definitely cannot prevent its users from making bad decisions and huge mistakes. From Google’s Bard AI chatbot making accusations about Big Four consulting firms to deep fakes about famous singers and politicians flooding the internet, many controversial AI incidents impact our society.

article thumbnail

New patent for Medicines360 drug LILETTA

Drug Patent Watch

Annual Drug Patent Expirations for LILETTA Liletta is a drug marketed by Medicines360 and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

59
article thumbnail

The comprehensive guide to leveraging healthcare data for sales and marketing success

Definitive Healthcare

The comprehensive guide to leveraging healthcare data for sales and marketing success mgathers Fri, 07/05/2024 - 16:14 Teaser Image the-comprehensive-guide-to-leveraging-healthcare-data-for-sales-and-marketing-success-teaser.png Teaser Content Download our e-book to discover how to plan and execute successful sales and marketing campaigns and accelerate success.

52
article thumbnail

New patent for Deciphera Pharms drug QINLOCK

Drug Patent Watch

Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. It is available from one supplier.

59